Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hemostemix Inc
(OP:
HMTXF
)
0.0693
-0.0027 (-3.75%)
Streaming Delayed Price
Updated: 12:55 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,001
Open
0.0671
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0720
Today's Range
0.0671 - 0.0693
52wk Range
0.0240 - 0.0790
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Hemostemix Announces the Appointment of Dr. Ernst von Schwarz, MD, PhD, FESC, FACC, FSCAI to Its Scientific Advisory Board
September 27, 2022
Calgary, Alberta--(Newsfile Corp. - September 27, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company")...
Via
Newsfile
Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to Its Scientific Advisory Board
September 20, 2022
Calgary, Alberta--(Newsfile Corp. - September 20, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company")...
Via
Newsfile
Performance
YTD
+24.42%
+24.42%
1 Month
+34.56%
+34.56%
3 Month
+88.32%
+88.32%
6 Month
+104.42%
+104.42%
1 Year
+36.42%
+36.42%
More News
Read More
Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory Board
September 16, 2022
Via
Newsfile
Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board
September 15, 2022
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board
September 14, 2022
Via
Newsfile
Hemostemix Announces Its Presentation to the Emerging Growth Conference
September 14, 2022
Via
Newsfile
Topics
Economy
Intellectual Property
Exposures
COVID-19
Economy
Intellectual Property
Hemostemix Announces the Appointment of Thomas Abraham, CA as President, PreCerv Inc.
September 13, 2022
Via
Newsfile
Hemostemix Announces Closing of $2,750,000
April 26, 2022
Via
IssueWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemostemix Inc. Announces Intellectual Property Due Diligence and Data Audit Completed
April 13, 2022
Via
IssueWire
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Your Fountain of Youth Trademarked by Hemostemix Inc.
March 03, 2022
Via
IssueWire
Topics
Intellectual Property
Exposures
Intellectual Property
Hemostemix Announces Closing of UNIT Private Placement
March 03, 2022
Via
IssueWire
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
December 14, 2021
Via
Benzinga
Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years
September 14, 2021
Via
Newsfile
Topics
Economy
Intellectual Property
Exposures
COVID-19
Economy
Intellectual Property
Hemostemix Provides Update of Phase II Clinical Trial, 9th Circuit Court Decision Including Cost Award and its Annual General Meeting Results
July 06, 2021
Via
Newsfile
Topics
Economy
Intellectual Property
Exposures
COVID-19
Economy
Intellectual Property
Peter Lacey Increases His Investment in Hemostemix Inc.
June 21, 2021
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture
June 11, 2021
Via
Newsfile
Topics
Economy
Intellectual Property
Exposures
COVID-19
Economy
Intellectual Property
Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list
April 23, 2021
Via
Newsfile
Topics
Economy
Intellectual Property
Exposures
COVID-19
Economy
Intellectual Property
Hemostemix Announces It Is Trading on the Frankfurt Stock Exchange and It Has Retained HE Capital Markets Ltd.
April 08, 2021
Via
Newsfile
Topics
Economy
Intellectual Property
Exposures
COVID-19
Economy
Intellectual Property
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
